Cargando…
Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells?
There is an emerging body of evidence that chemoresistance and minimal residual disease result from selective resistance of a cell subpopulation from the original tumor that is molecularly and phenotypically distinct. These cells are called “cancer stem cells” (CSCs). In this review, we analyze the...
Autores principales: | Paldino, Emanuela, Tesori, Valentina, Casalbore, Patrizia, Gasbarrini, Antonio, Puglisi, Maria Ausiliatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914574/ https://www.ncbi.nlm.nih.gov/pubmed/24527460 http://dx.doi.org/10.1155/2014/859871 |
Ejemplares similares
-
Therapeutic Implications of Mesenchymal Stem Cells in Liver Injury
por: Puglisi, Maria Ausiliatrice, et al.
Publicado: (2011) -
PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals
por: Cenciarelli, Carlo, et al.
Publicado: (2016) -
Correction: PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals
por: Cenciarelli, Carlo, et al.
Publicado: (2017) -
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
por: Tesori, Valentina, et al.
Publicado: (2015) -
PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment
por: Cenciarelli, Carlo, et al.
Publicado: (2014)